A086040 logo

Biotoxtech Co., Ltd. Stock Price

KOSDAQ:A086040 Community·₩43.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A086040 Share Price Performance

₩0
-3390.00 (-100.00%)
₩0
-3390.00 (-100.00%)
Price ₩0

A086040 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk with questionable track record.

3 Risks
1 Reward

Biotoxtech Co., Ltd. Key Details

₩44.2b

Revenue

₩39.8b

Cost of Revenue

₩4.4b

Gross Profit

₩3.5b

Other Expenses

₩879.5m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
55.94
9.88%
1.99%
184.1%
View Full Analysis

About A086040

Founded
2000
Employees
198
CEO
Jong-Koo Kang
WebsiteView website
www.biotoxtech.com

Biotoxtech Co., Ltd. engages in the safety evaluation of synthetic medicines, biomedicines, cell therapy products, gene therapy products, health functional foods, chemicals, and pesticides in South Korea. It is involved in testing and substance screening, clinical pathology and histopathology work, and consulting and government affairs related to non-clinical trials, as well as new drug development. The company’s safety evaluation research field includes general toxicity test, carcinogenicity studies, local toxicity studies, reproductive and developmental studies, genotoxicity test, immunotoxicity test, safety pharmacology test, aquatic ecotoxicology test, histopathology/clinical pathology, and animal testing method. Biotoxtech Co., Ltd. was founded in 2000 and is headquartered in Cheongwon, South Korea.

Recent A086040 News & Updates

Recent updates

No updates